Claudia Riedl

Director/Board Member at VIVORYON THERAPEUTICS N.V.

Net worth: 1 375 $ as of 31/07/2026

56 year

13 connections

Health Technology

Consumer Services

Commercial Services

Profile

Dr. Claudia Riedl is an Independent Non-Executive Director at Vivoryon Therapeutics NV.
She is on the Board of Directors at Vivoryon Therapeutics NV.
Dr. Riedl was previously employed as a Head-Corporate Communications & Investor Relations by MorphoSys AG.
She received her doctorate degree from Technische Universität München.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
VIVORYON THERAPEUTICS N.V. 0%	30/06/2025	1,000 ( 0% )	1 375 $	31/07/2026

Claudia Riedl active positions

Companies	Position	Start
VIVORYON THERAPEUTICS N.V.	Director/Board Member	01/01/2022

All active positions of Claudia Riedl

Former positions of Claudia Riedl

Companies	Position	End
MORPHOSYS AG	Public Communications Contact	01/01/2016

See the detail of Claudia Riedl's experience

Training of Claudia Riedl

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Claudia Riedl's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
MorphoSys AG MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services	Health Technology
Technische Universität München Technische Universität München Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Vivoryon Therapeutics NV Vivoryon Therapeutics NV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that is engaged in the research and development of new therapeutic products for the treatment of Alzheimer disease	Commercial Services